From: Nano drug delivery systems: a promising approach to scar prevention and treatment
Nanomaterial | biomolecule or drug | Model | Major outcomes | Ref |
---|---|---|---|---|
Aligned carbon nanotubes (ACNTs) film | — | Rabbit ear model of hypertrophic scars (HS) | Ideal inhibitory effect on HS; suppressing cell proliferation, and guiding growth direction | [40] |
Polycaprolactone(PCL) based electrospun nanofibrous mats (ENMs) | α-lactalbumin(ALA) | Rat deep second-degree burn model | Reduction of scar formation; accelerated wound healing and anti-inflammatory effects | [41] |
Anisotropic Silver Nanoparticles (AgNPs) loaded Composite chitosan(Ch) electrospun nanofiber | Cur | Rat full-thickness skin wound model | Less scar formation; promotion of wound healing and antibacterial activity | [42] |
Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanofibrous meshes | — | Mouse full-thickness skin wound model | Mitigated excessive scar formation; improved re-epithelization and mitigated wound contraction | [43] |
Cellulose acetate (CA)/soy protein hydrolysate (SPH) nanofibers scaffolds | — | Mouse excisional wound splinting model | Reduced scar formation; accelerated wound closure and tissue regeneration | [44] |
Bilayer membranous (BLM) nanofiber scaffold | Decellular dermis matrix | Rabbit ear wound model | Inhibit the formation of hypertrophic scars; inhibit collagen fiber deposition and angiogenesis | [45] |
Functionalized electrospun double-layer nanofibrous scaffold | Quaternized chitosan and silicone | Rabbit ear wound model | Inhibits scar formation, resists bacteria, promotes wound healing | [46] |
Poly(ε-caprolactone)/gelatin (Gel) nanofibrous scaffolds (PCL/GE/PALs) | Palmatine | Rabbit ear model of HS | Significantly inhibition of HS formation; accelerated wound healing, decreased density of microvascular | [47] |
Electrospun poly (L-lactide-co-glycolide)/gelatin (PLGA/Gel) membranes | ZnO nanoparticles and liraglutide | Rat bacterial-infected wound model | Scar length reduction; fast wound healing rate and antibacterial effect | [48] |
Electrospun nanofibrous silk fibroin (SF)/GEL electrospun nanofiber | Astragaloside IV | Rat acute wound model | Anti-scar effect; accelerated healing, enhanced angiogenesis, and arrangement of collagen | [49] |
Nanofibrous Electrospun Heart Decellularized Extracellular Matrix-based Hybrid Scaffold(NEhdHS) | — | Rat full-thickness skin wound model | Reduced scarring in the wound healing process | [50] |
Rg3-loaded nanoin-micro electrospun composite fibers | 20Â S-Ginsenoside Rg3 (Rg3) | Rabbit ear model of HS | Inhibition of HS formation; reduced collagen deposition and vascularization; more sustainable drug release | [51] |
PLGA nanoparticles in polyethylene glycol diacrylate (PEGDA) core/alginate shell structured hydrogel particles | hydrophobic corticosteroid | Rabbit ear wound model | Exhibited suppress scar formation; sustainable drug release over 4 weeks | [52] |
Cerium oxide (CeO2) nanocapsules (NCs) Adhered plasma-etched polylactic acid (PLA)-fiber membranes | Pirfenidone(PFD) | Mouse wound-healing odel | Satisfactory wound-repairing and anti-scarring effects | [53] |
Cerium oxide nanoparticles (CONPs)-loaded Poly-L-lactic acid (PLLA)-gelatin composite fiber membranes | — | Rats scalding model | Better scar remodeling effect and regenerative performance compared to other groups | [54] |